GHK-Cu in Canada

GHK-Cu is a copper-binding tripeptide (Gly-His-Lys copper complex). The published work on it is in rat, human, mouse and cell culture. Borealis Peptides supplies it as lyophilised powder in 50 mg and 100 mg vials for in-vitro laboratory research. It is not authorized as a medicine and is not for use in any living subject. Each study on this page carries its model and the outcome its authors recorded.

Borealis Peptides ships GHK-Cu from Canadian stock to research and business addresses in Canada. It is held in 50 mg and 100 mg vials. Every batch is tested by HPLC and the certificate names the batch in your vial. Orders are accepted for laboratory research only.

GHK-Cu does not appear in the Drug Product Database as an authorized product. It has had no safety, efficacy or quality review from Health Canada. Borealis Peptides holds it for in-vitro research; it is not supplied for use in any living subject. Health Canada has said that "Research Use Only" labelling does not make a product legal to use in a person, so we treat it as a description of what the material is supplied for rather than a permission. Lawful use in your own setting is yours to establish.

We do not answer dosing questions. GHK-Cu is not supplied for use in a person or an animal, so there is no dose to describe. What this page carries is the amount each cited study used and the model it used it in, reproduced as the authors published it.

Of the 8 studies cited, one is a controlled trial in people and the rest are animal or cell work. Each row names its model, the amount used and what the authors reported, so the weight of each study can be judged directly rather than through a summary.

Unopened, keep it at −20 °C in the dark. Solutions are held at 2–8 °C. Ambient transit does not harm the dry powder, which should be refrigerated once received. Keeping it dark and at a steady temperature matters more than how fast it arrived.

Every batch is tested by HPLC before it is sold, and the certificate refers to the batch in your vial rather than to the product in general. Keeping that batch number with your records is what makes an observation reproducible later. Certificates are available on request.

Each has its own published record, and comparing them is a matter of reading both. GLOW blend and KLOW have 8 cited studies and 8 cited studies on their page against 8 here. The useful comparison is between the two study tables and the models behind them.

Because it was among the peptides seized from sellers offering unauthorized injectable products online. The advisory concerns material sold for people to inject without authorization. Borealis Peptides supplies research material for laboratory use and sells nothing for injection or for any use in a person, which is the line that advisory draws.